TY - STD TI - Rosenfeld PJ, Brown DM, Heier JS, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 2006; 5;355(14):1419–1431. ID - ref1 ER - TY - JOUR AU - Wong, C. W. AU - Yanagi, Y. AU - Lee, W. K. PY - 2016 DA - 2016// TI - Age-related macular degeneration and polypoidalchoroidal vasculopathy in Asians JO - ProgRetin Eye Res VL - S1350–9462 ID - Wong2016 ER - TY - STD TI - Lim LS, Mitchell P, Seddon JM, et al. Age-related macular degeneration. Lancet 2012; 5;379(9827):1728–1738. ID - ref3 ER - TY - JOUR AU - Hashemi, H. AU - Khabazkhoob, M. AU - Nabovati, P. PY - 2017 DA - 2017// TI - The prevalence of age-related eye disease in an elderly population JO - Ophthalmic Epidemiol VL - 24 UR - https://doi.org/10.1080/09286586.2016.1270335 DO - 10.1080/09286586.2016.1270335 ID - Hashemi2017 ER - TY - JOUR AU - Friedman, D. S. AU - O’Colmain, B. J. AU - Munoz, B. PY - 2004 DA - 2004// TI - Prevalence of age-related macular degeneration in the United States JO - Arch Ophthalmol VL - 122 UR - https://doi.org/10.1001/archopht.122.7.1019 DO - 10.1001/archopht.122.7.1019 ID - Friedman2004 ER - TY - STD TI - Yadav S, Parry DG, Beare NA, et al. Polypoidal choroidal vasculopathy: a common type of neovascular age-related macular degeneration in Caucasians. Br J Ophthalmol. 2017; https://doi.org/10.1136/bjophthalmol-2016-310074. ID - ref6 ER - TY - JOUR AU - Chan, N. S. AU - Teo, K. AU - Cheung, C. M. PY - 2016 DA - 2016// TI - Epidemiology and diagnosis of myopic choroidal neovascularization in Asia JO - Eye Contact Lens VL - 42 UR - https://doi.org/10.1097/ICL.0000000000000201 DO - 10.1097/ICL.0000000000000201 ID - Chan2016 ER - TY - JOUR AU - Giuffrè, C. AU - Querques, L. AU - Carnevali, A. PY - 2017 DA - 2017// TI - Choroidal neovascularization and coincident perforating scleral vessels in pathologic myopia JO - Eur J Ophthalmol VL - 27 UR - https://doi.org/10.5301/ejo.5000875 DO - 10.5301/ejo.5000875 ID - Giuffrè2017 ER - TY - JOUR AU - Tong, Y. AU - Zhao, K. K. AU - Feng, D. PY - 2016 DA - 2016// TI - Comparison of the efficacy of anti-VEGF monotherapy versus PDT and intravitreal anti-VEGF combination treatment in AMD: a meta-analysis and systematic review JO - Int J Ophthalmol VL - 9 ID - Tong2016 ER - TY - JOUR AU - Teo, K. Y. C. AU - Wei, Y. N. AU - Shu, Y. L. PY - 2016 DA - 2016// TI - Management of Myopic Choroidal Neovascularization: focus on anti-VEGF therapy JO - Drugs VL - 76 UR - https://doi.org/10.1007/s40265-016-0605-0 DO - 10.1007/s40265-016-0605-0 ID - Teo2016 ER - TY - JOUR AU - Zhang, M. AU - Yu, D. AU - Yang, C. PY - 2009 DA - 2009// TI - The pharmacology study of a new recombinant human VEGF receptor-fc fusion protein on experimental choroidal neovascularization JO - Pharm Res VL - 26 UR - https://doi.org/10.1007/s11095-008-9718-9 DO - 10.1007/s11095-008-9718-9 ID - Zhang2009 ER - TY - JOUR AU - Zhang, M. AU - Zhang, J. AU - Yan, M. PY - 2011 DA - 2011// TI - A phase 1 study of KH902, a vascular endothelial growth factor receptor decoy, for exudative age-related macular degeneration JO - Ophthalmology VL - 118 UR - https://doi.org/10.1016/j.ophtha.2010.08.008 DO - 10.1016/j.ophtha.2010.08.008 ID - Zhang2011 ER - TY - JOUR AU - Qu, J. AU - Cheng, Y. AU - Li, X. PY - 2016 DA - 2016// TI - Efficacy of intravitreal injection of conbercept in polypoidal choroidal vasculopathy: Subgroup Analysis of the Aurora Study JO - Retina VL - 36 UR - https://doi.org/10.1097/IAE.0000000000000875 DO - 10.1097/IAE.0000000000000875 ID - Qu2016 ER - TY - JOUR AU - Li, X. AU - Xu, G. AU - Wang, Y. PY - 2014 DA - 2014// TI - Safety and efficacy of Conbercept in neovascular age-related macular degeneration: results from a 12-month randomized phase 2 study: AURORA study JO - Ophthalmology VL - 121 UR - https://doi.org/10.1016/j.ophtha.2014.03.026 DO - 10.1016/j.ophtha.2014.03.026 ID - Li2014 ER - TY - JOUR AU - Amoaku, W. M. AU - Chakravarthy, U. AU - Gale, R. PY - 2015 DA - 2015// TI - Definingresponse to anti-VEGF therapies in neovascular AMD JO - Eye VL - 29 UR - https://doi.org/10.1038/eye.2015.48 DO - 10.1038/eye.2015.48 ID - Amoaku2015 ER - TY - JOUR AU - Kitchens, J. W. AU - Do, D. V. AU - Boyer, D. S. PY - 2016 DA - 2016// TI - Comprehensive review of ocular and systemic safety events with intravitreal Aflibercept injection in randomized controlled trials JO - Ophthalmology VL - 123 UR - https://doi.org/10.1016/j.ophtha.2016.02.046 DO - 10.1016/j.ophtha.2016.02.046 ID - Kitchens2016 ER - TY - JOUR AU - Rosenfeld, P. J. AU - Rich, R. M. AU - Lalwani, G. A. PY - 2006 DA - 2006// TI - Ranibizumab: Phase III clinical trial results JO - Ophthalmol Clin N Am VL - 19 ID - Rosenfeld2006 ER - TY - STD TI - Kurt MM, Çekiç O, Akpolat Ç, et al. Comparative Retinal Vessel Size Study of Intravitreal Ranibizumab and Bevacizumab in Eyes with Neovascular Age-Related Macular Degeneration. Ophthalmologica. 2017; https://doi.org/10.1159/000477180. ID - ref18 ER - TY - STD TI - Avery RL, Castellarin AA, Steinle NC, et al. Systemic pharmacokinetics and pharmacodynamics of intravitreal aflibercept, bevacizumab, and ranibizumab. Retina. 2017;37(10):1847-58. ID - ref19 ER - TY - STD TI - Ikuno Y, Ohno-Matsui K, Wong TY, et al. Intravitreal Aflibercept Injection in Patients with Myopic Choroidal Neovascularization: The MYRROR Study. Ophthalmol. 2015;122(6):1220-7. ID - ref20 ER - TY - JOUR AU - Zhang, M. AU - Zhang, J. AU - Yan, M. PY - 2011 DA - 2011// TI - KH902 phase 1 study group. A phase 1 study of KH902, a vascular endothelial growth factor receptor decoy, for exudative age-related macular degeneration JO - Ophthalmology VL - 118 UR - https://doi.org/10.1016/j.ophtha.2010.08.008 DO - 10.1016/j.ophtha.2010.08.008 ID - Zhang2011 ER - TY - STD TI - Chang YS, Kim JH, Kim JW, et al. Intravitreal anti-vascular endothelial growth factor for treating Polypoidal choroidal vasculopathy with grape-like polyp clusters. Korean J Ophthalmol. 2016;30(4):272–9. ID - ref22 ER - TY - JOUR AU - Ting, D. S. AU - Ng, W. Y. AU - Ng, S. R. PY - 2016 DA - 2016// TI - Choroidal thickness changes in age-related macular degeneration and Polypoidal choroidal vasculopathy: a 12-month prospective study JO - Am J Ophthalmol VL - 164 UR - https://doi.org/10.1016/j.ajo.2015.12.024 DO - 10.1016/j.ajo.2015.12.024 ID - Ting2016 ER - TY - STD TI - Hikichi T. Six-year outcomes of antivascular endothelial growth factor monotherapy for polypoidal choroidal vasculopathy. Br J Ophthalmol. 2018;102(1):97-101. ID - ref24 ER - TY - JOUR AU - Martin, D. F. AU - Maguire, M. G. PY - 2012 DA - 2012// TI - Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results JO - Ophthalmology VL - 119 UR - https://doi.org/10.1016/j.ophtha.2012.03.053 DO - 10.1016/j.ophtha.2012.03.053 ID - Martin2012 ER - TY - JOUR AU - Heier, J. S. AU - Brown, D. M. AU - Chong, V. PY - 2012 DA - 2012// TI - Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration JO - Ophthalmology VL - 119 UR - https://doi.org/10.1016/j.ophtha.2012.09.006 DO - 10.1016/j.ophtha.2012.09.006 ID - Heier2012 ER - TY - JOUR AU - Wykoff, C. C. AU - Brown, D. M. AU - Maldonado, M. E. PY - 2014 DA - 2014// TI - Aflibercept treatment for patients with exudative age-related macular degeneration who were incomplete responders to multiple ranibizumab injections (TURF trial) JO - Br J Ophthalmol VL - 98 UR - https://doi.org/10.1136/bjophthalmol-2013-304736 DO - 10.1136/bjophthalmol-2013-304736 ID - Wykoff2014 ER -